Cargando…
Updates on Immune Therapies in Type 1 Diabetes
Multiple clinical trials investigating the efficacy and safety of immunotherapeutic interventions in new onset type 1 diabetes (T1D) have failed to yield long term clinical benefit. Lack of efficacy has frequently been attributed to an incomplete understanding of the pathways involved in T1D and the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Touch Medical Media
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813448/ https://www.ncbi.nlm.nih.gov/pubmed/29632594 http://dx.doi.org/10.17925/EE.2016.12.02.89 |